AIDS Drug Assistance Programs (ADAPs) in 10 states have a combined total of 1,001 people on waiting lists as of April 30, according to a new report from the National Alliance of State and Territorial AIDS Directors (NASTAD).

Sixteen other states have restricted access to ADAPs by lowering financial eligibility criteria, removing drugs from their formulary and limiting expenditures.

NASTAD's 2010 National ADAP Monitoring Project Annual Report states that “ADAPs are currently in the eye of the ‘perfect storm': minimal increases in federal appropriations, significant state budget cuts, increased program demand due to unemployment, heightened national efforts on HIV testing and linkages into care, and new HIV treatment guidelines calling for earlier therapeutic treatments.”

NASTAD will soon convene an ADAP Crisis Task Force to negotiate with antiretroviral manufacturers to provide more rebates and discounts, as well as multiyear cost protections.